| Over a month ago |
|
On The Fly
|
The most talked about and… ShowHide Related Items >><< - 04/27/23
- Wolfspeed falls -12.6%
- 04/27/23
- Wolfspeed falls -12.0%
- 04/26/23
- Wolfspeed falls 6% after Q4 guidance misses estimates
- 02/01/23
- Wolfspeed, ZF announce plans for joint research facility in Germany
- 04/06/23
- Silgan Holdings director D. Greg Horrigan will not seek reelection
- 03/08/23
- Silgan Holdings announces Kimberly Ulmer elected CFO
- 02/21/23
- Silgan Holdings raises dividend 12.5% to 18c per share
- 04/19/23
- Waze on Google built-in now available on Volvo, Polestar 2 cars
- 04/12/23
- EPA proposes 'strongest-ever pollution standards for cars and trucks'
- 04/06/23
- Polestar delivers 12,000 vehicles in Q1, up 26%
- 02/14/23
- Elliott buys NiSource, cuts Aerojet in Q4
- 04/26/23
- Microsoft to bring all 365 apps into cloud.microsoft domain
- 04/26/23
- Activision CEO says 'will work aggressively' with Microsoft to appeal
- 04/26/23
- ODP Corporation expands relationship with Microsoft
- 04/26/23
- Activision CEO says CMA decision 'far from final word' on Microsoft deal
- 12/20/22
- Model N falls -7.1%
- $146.53 /
+1.565 (+1.08%) - 04/05/23
- FirstService Residential acquired Crossbridge Condominium Services
- 02/06/23
- FirstService increases quarterly cash dividend 11% to 22.5c per share
- 01/12/23
- FirstService acquires Charles H. Greenthal & Co. and Tudor, no terms
- 12/20/22
- FirstService completes three tuck-under acquisitions
- $462.99 /
+10.59 (+2.34%) - 04/19/23
- Elevance Health reports Medical enrollment of 48.1M members on March 31
- 03/28/23
- The Standard to acquire Life & Disability business from Elevance Health
- 02/02/23
- Managed care stocks pressured after CMS' preliminary Medicare Advantage rates
- 01/25/23
- Elevance Health raises share repurchase program by $5B
- 01/10/23
- Emerald Holding acquires Lodestone Events
- 11/25/22
- Emerald Holding rises 5.7%
- 04/19/23
- Capcom's 'Resident Evil 4' top-selling game in U.S. in March, says Circana
- 04/10/23
- Sony says 'Resident Evil 4' most downloaded PS5 game in March in U.S., EU
- 04/06/23
- Electronic Arts reveals new brand vision, identity and logo for 'EA Sports FC'
- 04/03/23
- Electronic Arts Chairman Wilson sells over $1.2M in shares
- 04/06/23
- Cintas CAO Michael Thompson to retire, Jim Rozakis named COO
- 12/16/22
- Cintas launches electric vehicle pilot program
- 11/15/22
- Cintas expands cleanroom footprint with new facility in New York
- $162.97 /
-68.2 (-29.50%) - 04/24/23
- InterDigital appoints Skip Maloney as chief people officer
- 04/26/23
- Activision calls CMA decision 'irrational and inconsistent with the evidence'
- 04/26/23
- Microsoft says to appeal CMA determination, 'fully committed' to Activision deal
- $66.40 /
-8.015 (-10.77%) - 04/27/23
- ASGN falls -11.5%
- 04/25/23
- Albany International awarded army contract for 3D weaving technology
- 03/23/23
- Albany International CFO Stephen Nolan resigns
- 03/13/23
- Albany International CEO Bill Higgins to retire
- 02/14/23
- Albany International falls -15.1%
- $462.99 /
+10.59 (+2.34%) - 04/27/23 Morgan Stanley
- Elevance Health upgraded to Overweight from Equal Weight at Morgan Stanley
- 04/24/23 Wells Fargo
- Elevance Health price target lowered to $561 from $597 at Wells Fargo
- 04/21/23 Loop Capital
- Elevance Health price target lowered to $550 from $565 at Loop Capital
- 04/20/23 Cantor Fitzgerald
- Elevance Health initiated with an Overweight at Cantor Fitzgerald
- 04/27/23 Piper Sandler
- 2U price target lowered to $6 from $10 at Piper Sandler
- 04/27/23 Cantor Fitzgerald
- Cantor upgrades 2U on attractive risk/reward after selloff
- 04/27/23 Cantor Fitzgerald
- 2U upgraded to Overweight from Neutral at Cantor Fitzgerald
- 03/31/23 Morgan Stanley
- Udemy price target lowered to $14 from $15 at Morgan Stanley
- 04/27/23 Truist
- Albany International upgraded to Buy at Truist on valuation
- 04/27/23 Truist
- Albany International upgraded to Buy from Hold at Truist
- 01/09/23 Truist
- Albany International price target raised to $85 from $80 at Truist
- 10/26/22 Baird
- Albany International price target raised to $101 from $95 at Baird
- $146.53 /
+1.565 (+1.08%) - 04/27/23 Deutsche Bank
- FirstService price target raised to $145 from $143 at Deutsche Bank
- 04/27/23 TD Securities
- FirstService upgraded to Buy from Hold at TD Securities
- 04/19/23 RBC Capital
- FirstService initiated with an Outperform at RBC Capital
- 09/27/22 Scotiabank
- FirstService assumed at Outperform from Sector Perform at Scotiabank
- 04/27/23 Raymond James
- Silgan Holdings price target lowered to $55 from $60 at Raymond James
- 04/27/23 Citi
- Silgan Holdings upgraded to Buy from Neutral at Citi
- 04/20/23 BofA
- Silgan Holdings price target raised to $64 from $60 at BofA
- 01/26/23 Baird
- Silgan Holdings price target raised to $53 from $50 at Baird
- 04/27/23 Wells Fargo
- Wolfspeed price target lowered to $80 from $110 at Wells Fargo
- 04/27/23 Piper Sandler
- Wolfspeed price target lowered to $75 from $100 at Piper Sandler
- 04/27/23 Roth MKM
- Wolfspeed price target lowered to $71 from $95 at Roth MKM
- 04/27/23 Canaccord
- Wolfspeed price target lowered to $72 from $103 at Canaccord
- $162.97 /
-68.2 (-29.50%) - 04/27/23 Loop Capital
- Aspen Technology price target lowered to $240 from $270 at Loop Capital
- 04/27/23 William Blair
- William Blair downgrades Aspen Technology on chemical softness
- 04/27/23 William Blair
- Aspen Technology downgraded to Market Perform from Outperform at William Blair
- 04/18/23 KeyBanc
- Aspen Technology price target raised to $260 from $244 at KeyBanc
- $66.40 /
-8.015 (-10.77%) - 04/27/23 Truist
- ASGN price target lowered to $102 from $110 at Truist
- 04/27/23 BofA
- ASGN double downgraded to Underperform at BofA
- 02/09/23 Baird
- ASGN price target lowered to $103 from $108 at Baird
- 04/27/23 Barclays
- Barclays ups Activision target, sees 'strong buying opportunity'
- 04/27/23 BMO Capital
- Electronic Arts downgraded to Market Perform from Outperform at BMO Capital
- 04/26/23 Oppenheimer
- Oppenheimer sees Activision standalone value in mid-$80s per share
- 04/13/23 Barclays
- Electronic Arts price target raised to $124 from $118 at Barclays
- 04/27/23 BMO Capital
- Activision Blizzard price target raised to $100 from $95 at BMO Capital
- 04/27/23 Deutsche Bank
- Deutsche drops chances of Activision takeover by Microsoft to 10%
- 04/27/23 Stifel
- ServiceNow price target raised to $525 from $495 at Stifel
- 04/27/23 Citi
- Citi drops probability of Activision takeover closing to 20%
- 04/27/23 Baird
- Activision Blizzard price target lowered to $90 from $95 at Baird
- 04/27/23 Citi
- Cintas initiated with a Buy at Citi
- 04/04/23 Stifel
- Aramark price target lowered to $42 from $45 at Stifel
- 03/31/23 Jefferies
- Cintas downgraded to Hold from Buy at Jefferies
- 03/30/23 BofA
- Cintas price target raised to $523 from $513 at BofA
- 04/27/23 Cantor Fitzgerald
- Polestar Automotive initiated with an Overweight at Cantor Fitzgerald
- 04/27/23 Cantor Fitzgerald
- Polestar Automotive initiated with an Overweight at Cantor Fitzgerald
- 04/12/23 Fox Advisors
- Polestar Automotive initiated with an Outperform at Fox Advisors
- 03/06/23 Deutsche Bank
- Polestar price target lowered to EUR 7 from EUR 9 at Deutsche Bank
- 04/27/23 RBC Capital
- Model N initiated with a Sector Perform at RBC Capital
- 03/27/23 Morgan Stanley
- Model N initiated with an Overweight at Morgan Stanley
- 02/08/23 BTIG
- Model N price target raised to $48 from $42 at BTIG
- 02/08/23 Truist
- Model N price target raised to $52 from $45 at Truist
- 04/27/23 Maxim
- Emerald Holding initiated with a Buy at Maxim
- 04/27/23 Deutsche Bank
- Ocado Group initiated with a Hold at Deutsche Bank
- 04/11/23 Goldman Sachs
- Ocado Group initiated with a Neutral at Goldman Sachs
- 01/26/23 RBC Capital
- Ocado Group downgraded to Underperform from Sector Perform at RBC Capital
- 12/02/22 JPMorgan
- Ocado Group price target raised to 550 GBp from 500 GBp at JPMorgan
- 04/26/23
- Wolfspeed sees Q4 EPS (23c)-(17c), consensus (12c)
- 04/26/23
- Wolfspeed reports Q3 EPS (13c), consensus (15c)
- 01/25/23
- Wolfspeed sees Q3 EPS (16c) to (12c), consensus (6c)
- 01/25/23
- Wolfspeed reports Q2 EPS (11c), consensus (12c)
- 04/26/23
- 2U sees FY23 revenue $985M-$995M, consensus $988.45M
- 04/26/23
- 2U reports Q1 adjusted EPS (10c), consensus (7c)
- 02/02/23
- 2U reports Q4 adjusted EPS 23c vs 20c last year
- 11/07/22
- 2U reaffirms FY22 revenue view $960M, consensus $962.43M
- 04/26/23
- Silgan Holdings sees Q2 adjusted EPS 85c-95c, consensus $1.03
- 04/26/23
- Silgan Holdings backs 2023 adjusted EPS view $3.95-$4.15, consensus $4.02
- 04/26/23
- Silgan Holdings reports Q1 adjusted EPS 78c, consensus 77c
- 01/24/23
- Silgan Holdings sees FY23 EPS $3.95-$4.15, consensus $4.08
- 04/25/23
- Microsoft reports Q3 EPS $2.45, consensus $2.23
- 04/25/23
- Microsoft reports Q3 EPS $2.45, consensus $2.23
- 04/25/23
- Notable companies reporting after market close
- 01/24/23
- Microsoft reports Q2 adjusted EPS $2.32, consensus $2.29
- 02/07/23
- Model N sees FY23 EPS 90c-97c, consensus 93c
- 02/07/23
- Model N sees Q2 EPS 15c-18c, consensus 21c
- 02/07/23
- Model N reports Q1 EPS 23c, consensus 22c
- 11/09/22
- Model N sees FY23 revenue 90c-97c, consensus 77c
- $146.53 /
+1.565 (+1.08%) - 04/26/23
- FirstService reports Q1 adjusted EPS 85c, consensus 79c
- 02/07/23
- FirstService reports Q4 EPS $1.22, consensus $1.20
- $462.99 /
+10.59 (+2.34%) - 04/19/23
- Elevance Health raises FY23 adjusted EPS view to greater than $32.70 per share
- 04/19/23
- Elevance Health reports Q1 adjusted EPS 9.46, consensus $9.26
- 01/25/23
- Elevance Health sees FY23 adjusted EPS 'greater than' $32.60, consensus $32.69
- 01/25/23
- Elevance Health reports Q4 adjusted EPS $5.23, consensus $5.19
- 01/31/23
- EA sees mid-single digit top and bottom line growth in FY24
- 01/31/23
- Electronic Arts cuts FY23 EPS view to $2.97-$3.11 from $3.11-$3.34
- 01/31/23
- Electronic Arts sees Q4 EPS 5c-20c, consensus $2.22
- 01/31/23
- Electronic Arts reports Q3 EPS 73, consensus $3.05
- 03/29/23
- Cintas reports Q3 EPS $3.14, consensus $3.04
- 03/29/23
- Cintas raises FY23 EPS view to $12.70-$12.90 from $12.50-$12.80
- 03/29/23
- Cintas reports Q4 EPS $3.14, consensus $3.04
- 12/21/22
- Cintas raises FY23 EPS view to $12.50-$12.80 from $12.30-$12.65
- $162.97 /
-68.2 (-29.50%) - 04/26/23
- Aspen Technology cuts FY23 EPS view to $5.63-$5.83, consensus $7.06
- 04/26/23
- Aspen Technology reports Q3 adjusted EPS $1.06, consensus $1.74
- 01/25/23
- Aspen Technology raises FY23 EPS view to $6.83-$7.43 from $6.76-$6.91
- 01/25/23
- Aspen Technology reports Q2 adjusted EPS 35c, consensus $1.32
- 04/26/23
- Activision Blizzard reports Q1 adjusted EPS $1.09, consensus 52c
- 02/06/23
- Activision Blizzard reports Q4 adjusted EPS $1.09, consensus $1.51
- 02/06/23
- Notable companies reporting after market close
- 11/07/22
- Activision Blizzard reports Q3 adjusted EPS 68c, consensus 50c
- $66.40 /
-8.015 (-10.77%) - 04/27/23
- ASGN sees Q2 EPS $1.41-$1.56 , consensus $1.65
- 04/27/23
- ASGN reports Q1 EPS $1.38, consensus $1.42
- 02/08/23
- ASGN sees Q1 adjusted EPS $1.37-$1.45, consensus $1.49
- 02/08/23
- ASGN reports Q4 adjusted EPS $1.51, consensus $1.49
- 04/25/23
- Albany International affirms FY23 EPS $3.10-$3.60, consensus $3.64
- 04/25/23
- Albany International reports Q1 EPS 91c, consensus 82c
- 02/13/23
- Albany International sees FY23 EPS $3.10-$3.60, consensus $3.93
- 02/13/23
- Albany International reports Q4 EPS 75c, consensus 67c
- 03/28/23
- Second-hand Tesla cars losing value faster following price cuts, FT reports
- 04/25/23
- Microsoft plans to close Activision deal despite FTC challenge, NY Post says
- 04/25/23
- Meta to bring in Microsoft executive to lead chips effort, The Information says
- 04/24/23
- Microsoft would stop bundling Teams, Office to avoid formal EU probe, FT says
- 04/24/23
- Embracer's 'Dead Island 2' leads U.K. physical game sale charts, GI.biz says
- $462.99 /
+10.59 (+2.34%) - 11/29/22
- Managed care company returns will be tough to keep replicating, WSJ says
- 04/17/23
- Three 'Super Mario' games reach top ten in U.K. boxed charts, GI.biz says
- 03/27/23
- Capcom's 'RE4' remake eighth biggest series launch in U.K., GI.biz says
- 03/21/23
- 'WWE 2K23' passes 'Hogwarts Legacy' in U.K. boxed charts, GI.biz reports
- 03/01/23
- EA lays off more than 200 'Apex Legends' QA workers, Kotaku reports
- 04/06/23
- Sony says CMA reversal on Microsoft-Activision 'irrational,' Verge says
- 04/03/23
- DOJ sues Activision Blizzard over esports salary restrictions, Reuters says
- 03/22/23
- Microsoft says a decade enough time for Sony to make 'COD' alternative, VGC says
- 04/26/23
- Fly Intel: After-Hours Movers
- 04/03/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/06/23
- What You Missed This Week in EVs and Clean Energy
- 03/02/23
- Why are these three stocks sinking after Tesla's investor day?
- 02/02/23
- Fly Intel: After-Hours Movers
- 11/08/22
- What You Missed On Wall Street This Morning
- 04/12/23
- What You Missed On Wall Street On Wednesday
- 02/22/23
- Here's what Wall Street experts are saying about these EV names ahead of results
- 11/21/22
- What You Missed This Week in EVs and Clean Energy
- 11/16/22
- What You Missed On Wall Street On Wednesday
- 04/26/23
- What You Missed On Wall Street This Morning
- 04/26/23
- Fly Intel: Pre-market Movers
- 04/25/23
- What You Missed On Wall Street On Tuesday
- 02/07/23
- Fly Intel: After-Hours Movers
- 11/09/22
- What You Missed On Wall Street On Wednesday
- 11/09/22
- What You Missed On Wall Street This Morning
- $462.99 /
+10.59 (+2.34%) - 04/19/23
- What You Missed On Wall Street This Morning
- 03/28/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 04/11/23
- What You Missed This Week in Video Games
- 04/04/23
- What You Missed This Week in Video Games
- 03/30/23
- What You Missed On Wall Street On Thursday
- 03/30/23
- What You Missed On Wall Street This Morning
- 03/31/23
- What You Missed On Wall Street On Friday
- 03/31/23
- What You Missed On Wall Street This Morning
- 03/31/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/21/22
- What You Missed On Wall Street On Wednesday
- $162.97 /
-68.2 (-29.50%) - 01/25/23
- Fly Intel: After-Hours Movers
- 04/24/23
- What Wall Street is saying about Microsoft ahead of earnings
- 04/25/23
- Fly Intel: After-Hours Movers
- 04/26/23
- Wolfspeed options imply 10.2% move in share price post-earnings
- 01/25/23
- Wolfspeed options imply 10.1% move in share price post-earnings
- 04/24/23
- Largest borrow rate increases among liquid names
- 03/30/23
- Largest borrow rate increases among liquid names
- 02/27/23
- Polestar Automotive call volume above normal and directionally bullish
- 02/23/23
- Largest borrow rate increases among liquid names
- 04/27/23
- Notable open interest changes for April 27th
- 04/26/23
- Early notable gainers among liquid option names on April 26th
- 04/26/23
- Notable open interest changes for April 26th
- 04/25/23
- Microsoft options imply 3.6% move in share price post-earnings
- $462.99 /
+10.59 (+2.34%) - 01/25/23
- Early notable gainers among liquid option names on January 25th
- 04/26/23
- Electronic Arts put volume heavy and directionally bearish
- 04/04/23
- Early notable gainers among liquid option names on April 4th
- 03/24/23
- Early notable gainers among liquid option names on March 24th
- 02/14/23
- Largest borrow rate increases among liquid names
- 03/29/23
- Early notable gainers among liquid option names on March 29th
- 03/30/23
- Activision Blizzard put volume heavy and directionally bearish
- 03/30/23
- Notable open interest changes for March 30th
- 03/29/23
- Activision Blizzard put volume heavy and directionally bearish
- 03/27/23
- Notable open interest changes for March 27th
|
|
Initiation
|
Citi analyst Leo… Citi analyst Leo Carrington initiated coverage of Cintas with a Buy rating and $540 price target. Cintas is the leader in the "fragmented" workwear rental sector where the eight largest companies control less than 30% of the market, the analyst tells investors in a research note. Citi's new indices of employment and pricing highlight Cintas' "significant competitive advantage," contends the firm. It says the company provides a business-critical service in sectors where in-sourcing or having no-program is increasingly challenging. ShowHide Related Items >><< - $439.54 /
-7.665 (-1.71%) - 04/06/23
- Cintas CAO Michael Thompson to retire, Jim Rozakis named COO
- 12/16/22
- Cintas launches electric vehicle pilot program
- 11/15/22
- Cintas expands cleanroom footprint with new facility in New York
- $439.54 /
-7.665 (-1.71%) - 04/04/23 Stifel
- Aramark price target lowered to $42 from $45 at Stifel
- 03/31/23 Jefferies
- Cintas downgraded to Hold from Buy at Jefferies
- 03/30/23 BofA
- Cintas price target raised to $523 from $513 at BofA
- 03/30/23 Argus
- Cintas price target raised to $510 from $500 at Argus
- $439.54 /
-7.665 (-1.71%) - 03/29/23
- Cintas reports Q3 EPS $3.14, consensus $3.04
- 03/29/23
- Cintas raises FY23 EPS view to $12.70-$12.90 from $12.50-$12.80
- 03/29/23
- Cintas reports Q4 EPS $3.14, consensus $3.04
- 12/21/22
- Cintas raises FY23 EPS view to $12.50-$12.80 from $12.30-$12.65
- $439.54 /
-7.665 (-1.71%) - 03/31/23
- What You Missed On Wall Street On Friday
- 03/31/23
- What You Missed On Wall Street This Morning
- 03/31/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/21/22
- What You Missed On Wall Street On Wednesday
- $439.54 /
-7.665 (-1.71%) - 03/29/23
- Early notable gainers among liquid option names on March 29th
|
|
Hot Stocks
|
Cintas announced that… Cintas announced that Michael Thompson, Executive Vice President and Chief Administration Officer, will retire on August 31, 2023. Thompson will cease being an Executive Officer of the Company as of May 31, 2023. The company also announced that Jim Rozakis, currently President and COO of the company's Rental Division, will be promoted to Cintas EVP and COO, effective June 1, 2023. Cintas will not fill Thompson's CAO role at this time. Thompson's responsibilities and areas of oversight will be distributed among the company's executive administration. Rozakis will move into the COO role which has been unfilled since Todd Schneider, the last EVP and COO, was appointed to President and CEO in June 2021. ShowHide Related Items >><< - 12/16/22
- Cintas launches electric vehicle pilot program
- 11/15/22
- Cintas expands cleanroom footprint with new facility in New York
- 04/04/23 Stifel
- Aramark price target lowered to $42 from $45 at Stifel
- 03/31/23 Jefferies
- Cintas downgraded to Hold from Buy at Jefferies
- 03/30/23 BofA
- Cintas price target raised to $523 from $513 at BofA
- 03/30/23 Argus
- Cintas price target raised to $510 from $500 at Argus
- 03/29/23
- Cintas reports Q3 EPS $3.14, consensus $3.04
- 03/29/23
- Cintas raises FY23 EPS view to $12.70-$12.90 from $12.50-$12.80
- 03/29/23
- Cintas reports Q4 EPS $3.14, consensus $3.04
- 12/21/22
- Cintas raises FY23 EPS view to $12.50-$12.80 from $12.30-$12.65
- 03/31/23
- What You Missed On Wall Street On Friday
- 03/31/23
- What You Missed On Wall Street This Morning
- 03/31/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/21/22
- What You Missed On Wall Street On Wednesday
- 03/29/23
- Early notable gainers among liquid option names on March 29th
|
|
Recommendations
|
Stifel lowered the… Stifel lowered the firm's price target on Aramark (ARMK) to $42 from $45 and keeps a Buy rating on the shares. Given Cintas' (CTAS) "strong quarter," the firm doesn't expect macro headwinds to impact the Uniforms division results and it expects Aramark's commentary to be bullish around new deals and the potential for strong revenue growth, Stifel tells investors in an earnings preview note. ShowHide Related Items >><< - 12/16/22
- Cintas launches electric vehicle pilot program
- 11/15/22
- Cintas expands cleanroom footprint with new facility in New York
- 03/20/23
- S&P announces changes to S&P 400, 600 indices at open on 3/20
- 02/07/23
- Aramark falls -10.0%
- 02/02/23
- Aramark to sell 50% equity stake in AIM Services to Mitsui & Co, for $535M
- 03/22/23 Baird
- Aramark price target lowered to $39 from $43 at Baird
- 02/08/23 Deutsche Bank
- Aramark price target lowered to $44 from $46 at Deutsche Bank
- 02/07/23 Stifel
- Aramark should be bought amid expense reversal 'misunderstanding,' says Stifel
- 12/02/22 Barclays
- Aramark price target raised to $36 from $34 at Barclays
- 03/31/23 Jefferies
- Cintas downgraded to Hold from Buy at Jefferies
- 03/30/23 BofA
- Cintas price target raised to $523 from $513 at BofA
- 03/30/23 Argus
- Cintas price target raised to $510 from $500 at Argus
- 03/30/23 Stifel
- Cintas price target raised to $512 from $503 at Stifel
- 03/29/23
- Cintas reports Q3 EPS $3.14, consensus $3.04
- 03/29/23
- Cintas raises FY23 EPS view to $12.70-$12.90 from $12.50-$12.80
- 03/29/23
- Cintas reports Q4 EPS $3.14, consensus $3.04
- 12/21/22
- Cintas raises FY23 EPS view to $12.50-$12.80 from $12.30-$12.65
- 02/07/23
- Aramark backs FY23 organic revenue growth view 11%-13%
- 02/07/23
- Aramark reports Q1 adjusted EPS 44c, consensus 43c
- 11/15/22
- Aramark sees FY23 organic revenue growth 11%-13%
- 11/15/22
- Aramark reports Q4 adjusted EPS 49c, consensus 49c
- 03/31/23
- What You Missed On Wall Street On Friday
- 03/31/23
- What You Missed On Wall Street This Morning
- 03/31/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/21/22
- What You Missed On Wall Street On Wednesday
- 11/15/22
- What You Missed On Wall Street On Tuesday
- 11/15/22
- What You Missed On Wall Street This Morning
- 11/15/22
- Fly Intel: Pre-market Movers
- 03/29/23
- Early notable gainers among liquid option names on March 29th
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/30/23
- Virgin Orbit unable to secure funding, to cease operations, lay off 85% of staff
- 03/22/23
- Virgin Orbit confirms incremental resumption of operations
- 03/16/23
- Virgin Orbit confirms operational pause amid discussions for funding
- 02/14/23
- Virgin Orbit provides update on U.K. mission anomaly
- 03/28/23
- Viking Therapeutics initiates Phase 1 study of novel formulation of VK2735
- 03/28/23
- Viking Therapeutics jumps 32% to $12.06 after Phase 1 VK2735 trial results
- 03/28/23
- Viking Therapeutics announces results from Phase 1 trial of VK2735
- 01/09/23
- Viking Therapeutics completes enrollment in Phase 2b VOYAGE study of VK2809
- 03/13/23
- Thorne HealthTech appoints Varma as new CFO
- 02/03/23
- Thorne HealthTech acquires PreCon Health for $5M
- 01/09/23
- Appeals Court upholds Thorne HealthTech's prior challenge of NR IP claim
- 10/25/22
- Thorne HealthTech and Gentegra collaborate for DNA collection kit
- 03/29/23
- Semtech falls 8% to $29.40 after Q4 earnings miss, below-consensus guidance
- 03/28/23
- Semtech announces first LoRa-enabled third party products available
- 03/20/23
- Semtech enters into cooperation agreement with Lion Point Capital
- 03/16/23
- Semtech CEO Mohan Maheswaran to retire
- 03/31/23
- Rogers Communications sees 2023 service revenue up 26%-30%
- 03/31/23
- Rogers Communications, Shaw Communications to proceed with merger
- 03/31/23
- Rogers, Shaw, Quebecor to close pro-competitive transactions
- 02/17/23
- Shaw Communications extends date for annual general meeting
RCI Rogers Communications - 02/17/23
- Rogers, Shaw, Quebecor extend outside date of proposed transactions
- $11.57 /
+1.815 (+18.61%) - 03/28/23
- Pacific Biosciences announces new workflows developed with Corteva
- 03/07/23
- Pacific Biosciences begins commercial shipment of Revio sequencing systems
- 01/09/23
- Pacific Biosciences partners with University of Tokyo
- 03/30/23
- Chart Industries, Nikola execute strategic partnership
- 03/29/23
- Nikola, Klean Industries partner to convert truck fleets to FCEVs
- 03/29/23
- Nikola says has received orders for 100 Class 8 FCEVs
- 03/27/23
- Nikola CFO Kim Brady to retire, Anastasiya Pasterick to succeed
- 03/09/23
- Verizon offers one year of Netflix for free through its +play subscription hub
- 02/22/23
- Netflix announces first partnership with NFL for 'Quarterback' docu-series
- 02/08/23
- Netflix provides update on sharing guidelines as 100M households share accounts
- 02/02/23
- Netflix, GM partner to increase EV presence in Netflix-produced shows, films
- 03/31/23
- CAC announces cybersecurity review of Micron products selling in China
- 03/28/23
- Micron says now expects overall headcount reduction to approach 15%
- 03/28/23
- Micron says further reducing supply
- 03/28/23
- Micron up 2% after Q2 report
- 03/30/23
- JD.com intends to spin-off JD Property, JD Industrials
- 03/09/23
- JD.com initiates quarterly dividend of 62c per ADS
- 01/31/23
- Dada Nexus, JD.com announce results from JD Shop Now Spring Festival
- 12/27/22
- China stocks rising with borders set to reopen on January 8
- 03/31/23
- IonQ rises 29.9%
- 03/31/23
- IonQ rises 21.9%
- 03/31/23
- IonQ rises 6.9%
- 03/21/23
- IonQ mentioned by Nvidia among partners integrating CUDA Quantum
- 03/29/23
- Verint announces expanded partnership with Google Cloud
- 03/29/23
- Verint announces expanded partnership with Google CloudAlphabet
- 03/28/23
- Google teams with AI firm Replit to aid generative AI for software development
- 03/28/23
- ADT Inc., Google announce availability of ADT Self Setup home security system
- 03/30/23
- Globant expands global partnership with Google Cloud
- 03/31/23
- Generac falls -5.7%
- 03/31/23
- Generac falls -5.6%
- 03/07/23
- Generac makes strategic minority investment in Rolling Energy Resources
- 01/31/23
- Generac announces home standby generator integration with ecobee smart
- 03/22/23
- GM says sixth generation Chevrolet Camaro to retire at conclusion of 2024
- 03/22/23
- General Motors selects Adobe Experience Cloud
- 03/21/23
- EU passenger car registrations up 11.5% in February
- 03/09/23
- General Motors announces voluntary separation program
- 03/30/23
- Ford withdraws self-driving petition with NHTSA
- 03/30/23
- Ford enters three-party collaboration to advance nickel production in Indonesia
- 03/26/23
- Fly Intel: Top five weekend stock stories
- 03/24/23
- Ford says 'on track' with construction at BlueOval City mega-campus
- 12/16/22
- Cintas launches electric vehicle pilot program
- 11/15/22
- Cintas expands cleanroom footprint with new facility in New York
- 03/31/23
- Cano Health 'disappointed that three directors chose to resign'
- 03/30/23
- Cano Health's Barry Sternlicht resigns from board
- 02/14/23
- Third Point buys AIG, exits T-Mobile in Q4
- 10/17/22
- Cano Health falls -12.5%
- 03/16/23
- Bio-Path provides clinical, operational update
- 12/07/22
- Bio-Path announces first patient dosed in Phase 1/1b study of BP1001-A
- 11/07/22
- Bio-Path announces $2M registered direct offering, private placement
- 10/24/22
- Bio-Path announces first patient dosed in Phase 1/1b study of BP1002
- 03/28/23
- BIO-key strategically teams with Ethnos IT Solutions expanding Africa reach
- 03/14/23
- BIO-key, BeyondTrust announce integrated partnership
- 02/27/23
- City of Brawley, CA selects BIO-key's PortalGuard IDaaS platform
- 02/13/23
- BIO-key partners with Europe's Bravantic Group
- 03/31/23
- BlackBerry rises 14.8%
- 03/23/23
- BlackBerry, Adobe partner on secure forms solution for mobile
- 03/21/23
- BlackBerry to sell non-core patents, applications to Malikie for $900M
- 03/07/23
- BlackBerry falls -13.3%
- 02/28/23
- Arconic trading resumes
- 02/28/23
- Arconic jumps 10% to $24.29 after WSJ report of Apollo buyout talks
- 02/28/23
- Arconic trading halted, volatility trading pause
- 02/07/23
- Arconic reports $304M after-tax loss on sale of Russian operations
- 11/10/22
- Aon acquires risk assessment modeling firm ERN, terms not disclosed
- 03/31/23
- Aehr Test Systems provides update on ATM offering
- 03/21/23
- Aehr Test receives order from major silicon carbide semiconductor customer
- 03/14/23
- Aehr Test Systems receives $6.7M order for FOX WaferPak full water Contactors
- 03/10/23
- Aehr Test Systems believes 'no impact' to operations due to closure of SVB
- 03/30/23
- VirnetX disagrees with Federal Circuit's decision, evaluating options
- 03/30/23
- VirnetX lower after denied appeal in patent fight with Apple
- 03/30/23
- VirnetX enters cooperation agreement with Bradley Radoff and Michael Torok
- 03/29/23
- Apple WWDC to run from June 5-9
- 03/31/23 Stifel
- Stifel says gauging impact to Micron from China review 'speculative' for now
- 03/31/23 Wedbush
- Wedbush says 'difficult to understand ramifications' of China's Micron review
- 03/29/23 Needham
- Micron price target raised to $71 from $67 at Needham
- 03/29/23 Susquehanna
- Micron price target raised to $90 from $65 at Susquehanna
- 03/31/23 TD Securities
- BlackBerry upgraded to Hold at TD Securities following 68% decline
- 03/31/23 TD Securities
- BlackBerry upgraded to Hold from Reduce at TD Securities
- 03/08/23 RBC Capital
- BlackBerry price target lowered to C$4.50 from C$5.50 at RBC Capital
- 12/21/22 Canaccord
- BlackBerry price target lowered to $4.50 from $5.00 at Canaccord
- 03/31/23 BTIG
- BTIG downgrades Nikola to Neutral after stock offering, expects further dilution
- 03/31/23 BTIG
- Nikola downgraded to Neutral from Buy at BTIG
- 03/13/23 Morgan Stanley
- Nikola initiated with an Equal Weight at Morgan Stanley
- 02/24/23 Deutsche Bank
- Nikola price target lowered to $3 from $5 at Deutsche Bank
- 03/17/23 Canaccord
- Virgin Orbit rating, target put under review at Canaccord after operations halt
- 01/11/23 Canaccord
- Virgin Orbit price target lowered to $6 from $12
- 10/11/22 Credit Suisse
- Virgin Orbit initiated with Underperform on elevated cash burn at Credit Suisse
- 10/11/22 Credit Suisse
- Virgin Orbit initiated with an Underperform at Credit Suisse
- 03/29/23 Wells Fargo
- Netflix update on sharing efforts likely a positive catalyst, says Wells Fargo
- 03/20/23 JPMorgan
- Netflix Paid Sharing launches bring near-term 'noise,' says JPMorgan
- 03/16/23 Citi
- Netflix price target raised to $400 from $395 at Citi
- 03/15/23 Oppenheimer
- Netflix share pullback brings buying opportunity, says Oppenheimer
- 03/27/23 Citi
- General Motors price target lowered to $76 from $82 at Citi
- 03/21/23 Morgan Stanley
- EV price cuts 'not a fad, but a trend,' says Morgan Stanley
- 03/09/23 Citi
- WSJ report on GM didn't contain new information, says Citi
- 02/24/23 BofA
- GM should be bought, not sold, on truck production cut, says BofA
- 03/30/23 Needham
- Disney and Apple worth more together than separately, says Needham
- 03/28/23 Mizuho
- Apple 'Pay Later' should already be reflected in Affirm price, says Mizuho
- 03/28/23 Barclays
- Apple advertising on own apps is underappreciated, says Barclays
- 03/21/23 Morgan Stanley
- Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley
- 03/31/23 Piper Sandler
- Piper cuts Alphabet target on 'real risk' to Search revenue from AI
- 03/30/23 Credit Suisse
- YouTube engagement remains steady, says Credit Suisse
- 03/29/23 Morgan Stanley
- TikTok ban could put 53B U.S. consumer hours 'up for grabs,' says Morgan Stanley
- 03/29/23 KeyBanc
- Microsoft price target raised to $316 from $270 at KeyBanc
- 03/24/23 Barclays
- Meta Platforms price target raised to $270 from $260 at Barclays
- 01/06/23 UBS
- Cano Health downgraded to Neutral from Buy at UBS
- 01/05/23 Wolfe Research
- Cano Health downgraded to Peer Perform from Outperform at Wolfe Research
- 12/13/22 Citi
- Citi opens 'positive Catalyst Watch' on Cano Health
- 12/13/22 BofA
- BofA resumes Cano Health at Underperform, sees potential more guidance cuts
- $11.57 /
+1.815 (+18.61%) - 03/31/23 TD Cowen
- Pacific Biosciences upgraded to Outperform from Market Perform at TD Cowen
- 02/22/23 Piper Sandler
- Pacific Biosciences price target lowered to $10 from $11 at Piper Sandler
- 02/02/23 UBS
- Pacific Biosciences initiated with a Neutral at UBS
- 01/20/23 Cantor Fitzgerald
- Pacific Biosciences downgraded to Neutral at Cantor Fitzgerald on valuation
- 03/31/23 Jefferies
- Cintas downgraded to Hold from Buy at Jefferies
- 03/30/23 BofA
- Cintas price target raised to $523 from $513 at BofA
- 03/30/23 Argus
- Cintas price target raised to $510 from $500 at Argus
- 03/30/23 Stifel
- Cintas price target raised to $512 from $503 at Stifel
- 03/31/23 Loop Capital
- JD.com cut to Hold at Loop Capital amid continued competitive concerns
- 03/30/23 Loop Capital
- JD.com downgraded to Hold from Buy at Loop Capital
- 03/13/23 Susquehanna
- JD.com price target lowered to $45 from $62 at Susquehanna
- 03/13/23 Barclays
- JD.com price target raised to $74 from $72 at Barclays
- 03/31/23 BofA
- Generac downgraded to Underperform from Neutral at BofA
- 03/09/23 Citi
- Generac transferred with Neutral from Buy at Citi
- 03/03/23 Oppenheimer
- Generac price target raised to $145 from $137 at Oppenheimer
- 03/02/23 Scotiabank
- Generac initiated with a Sector Perform at Scotiabank
- 03/31/23 JPMorgan
- Aon plc price target raised to $322 from $320 at JPMorgan
- 02/14/23 Stifel
- Willis Towers Watson price target raised to $255 from $228 at Stifel
- 02/06/23 Piper Sandler
- Aon plc price target raised to $325 from $305 at Piper Sandler
- 01/19/23 BMO Capital
- Aon plc initiated with a Market Perform at BMO Capital
- 03/27/23 Citi
- Ford price target lowered to $12.50 from $14 at Citi
- 02/15/23 Tudor Pickering
- Ford downgraded to Hold from Buy at Tudor Pickering
- 02/14/23 Barclays
- Barclays starts autos and mobility sector, says Tesla stands out
- 01/13/23 Scotiabank
- Shaw Communications downgraded to Sector Perform from Outperform at Scotiabank
- 01/13/23 Scotiabank
- Shaw Communications downgraded to Sector Perform from Outperform at Scotiabank
- 01/13/23 Desjardins
- Shaw Communications downgraded to Hold from Buy at Desjardins
- 01/10/23 Canaccord
- Shaw Communications downgraded to Hold from Buy at Canaccord
RCI Rogers Communications - 02/06/23 UBS
- Rogers Communications upgraded to Buy from Neutral at UBS
- 02/03/23 Canaccord
- Rogers Communications price target raised to C$69 from C$68 at Canaccord
- 02/03/23 TD Securities
- Rogers Communications price target raised to C$78 from C$76 at TD Securities
- 02/03/23 Canaccord
- Rogers Communications price target raised to C$69 from C$68 at Canaccord
- 03/31/23 Baird
- Semtech price target lowered to $40 from $48 at Baird
- 03/30/23 Stifel
- Semtech price target lowered to $37 from $40 at Stifel
- 03/30/23 TD Cowen
- Semtech price target lowered to $28 from $33 at TD Cowen
- 03/30/23 Susquehanna
- Semtech price target lowered to $30 from $32 at Susquehanna
- 03/29/23 Truist
- Viking Therapeutics price target raised to $32 from $28 at Truist
- 03/29/23 Roth MKM
- Viking Therapeutics price target raised to $19 from $15 at Roth MKM
- 03/29/23 Maxim
- Viking Therapeutics price target raised to $25 from $15 at Maxim
- 03/29/23 Raymond James
- Viking Therapeutics price target raised to $35 from $12 at Raymond James
- 01/20/23 Craig-Hallum
- Aehr Test Systems price target raised to $45 from $31 at Craig-Hallum
- 10/17/22 William Blair
- Aehr Test Systems initiated with an Outperform at William Blair
- 11/16/22 Benchmark
- IonQ price target lowered to $8 from $12 at Benchmark
- 08/16/22 Benchmark
- IonQ price target lowered to $12 from $15 at Benchmark
- 07/15/22 Goldman Sachs
- IonQ price target lowered to $8 from $10 at Goldman Sachs
- 06/08/22 Needham
- Needham starts IonQ at Buy as market leader in ion trap quantum computers
- 05/18/22 H.C. Wainwright
- Bio-Path price target lowered to $9 from $12 at H.C. Wainwright
- 03/31/23 Craig-Hallum
- Fathom Digital downgraded to Hold from Buy at Craig-Hallum
- 11/11/22 JPMorgan
- Fathom Digital initiated with an Overweight at JPMorgan
- 08/16/22 Needham
- Fathom Digital price target lowered to $6 from $9 at Needham
- 05/17/22 Needham
- Fathom Digital price target lowered to $9 from $12 at Needham
- 11/16/22 Canaccord
- Thorne HealthTech initiated with Buy, $5.50 target at Canaccord
- 11/16/22 Canaccord
- Thorne HealthTech initiated with a Buy at Canaccord
- 08/11/22 TD Cowen
- Thorne HealthTech price target lowered to $8 from $12 at Cowen
- 02/28/23 Goldman Sachs
- Arconic downgraded to Sell from Neutral at Goldman Sachs
- 02/22/23 Deutsche Bank
- Arconic price target lowered to $21 from $23 at Deutsche Bank
- 01/24/23 Deutsche Bank
- Arconic price target raised to $23 from $22 at Deutsche Bank
- 12/15/22 Benchmark
- Arconic price target lowered to $26 from $30 at Benchmark
- 02/08/23
- Viking Therapeutics reports Q4 EPS (26c), consensus (23c)
- 10/26/22
- Viking Therapeutics reports Q3 EPS (21c), consensus (23c)
- 03/30/23
- Thorne HealthTech sees FY23 adjusted EPS 37c-39c, consensus 64c
- 03/30/23
- Thorne HealthTech reports Q4 adjusted EPS 13c vs. 7c last year
- 03/29/23
- Semtech sees Q1 EPS (11c)-(4c), consensus 43c
- 03/29/23
- Semtech reports Q4 EPS 47c, consensus 48c
- 11/30/22
- Semtech sees Q4 adjusted EPS 44c-52c, consensus 54c
- 11/30/22
- Semtech reports Q3 adjusted EPS 65c, consensus 63c
- 01/12/23
- Shaw Communications reports Q1 EPS C$0.34 vs. C$0.39 last year
- 11/29/22
- Shaw Communications reports Q4 EPS C$0.34, versus C$0.50 last year
RCI Rogers Communications - 02/02/23
- Rogers Communications sees 2023 service revenue up 4%-7%
- 02/02/23
- Rogers Communications reports Q4 adjusted EPS C$1.09 vs. C$0.96 last year
- 11/09/22
- Rogers Communications reports Q3 adjusted EPS C$0.84 vs C$1.03 last year
- $11.57 /
+1.815 (+18.61%) - 02/16/23
- Pacific Biosciences reports Q4 adjusted EPS (35c), consensus (36c)
- 01/09/23
- Pacific Biosciences sees Q4 revenue $27.3M, consensus $27.88M
- 11/07/22
- Pacific Biosciences withdraws all prior financial guidance
- 11/07/22
- Pacific Biosciences reports Q3 EPS (32c), consensus (33c)
- 02/23/23
- Nikola reports Q4 adjusted EPS (37c), consensus (43c)
- 02/22/23
- Notable companies reporting before tomorrow's open
- 11/03/22
- Nikola reports Q3 adjusted EPS (28c), consensus (39c)
- 01/19/23
- Netflix sees Q1 EPS $2.82, consensus $2.97
- 01/19/23
- Netflix reports Q4 EPS 12c, consensus 45c
- 01/19/23
- Notable companies reporting after market close
- 10/18/22
- Netflix sees Q4 EPS 36c, consensus $1.12
- 03/28/23
- Micron sees Q3 adjusted EPS ($1.65)-($1.51), consensus (90c)
- 03/28/23
- Micron reports Q2 adjusted EPS ($1.91), consensus (86c)
- 03/28/23
- Notable companies reporting after market close
- 03/02/23
- Micron sees lower margins in fiscal Q3 than previously expected
- 03/09/23
- JD.com reports Q4 EPS 70c, consensus 50c
- 03/08/23
- Notable companies reporting before tomorrow's open
- 11/18/22
- JD.com reports Q3 EPS 88c, consensus 63c
- 03/30/23
- IonQ sees FY23 revenue $18.4M-$18.8M, consensus $18.2M
- 03/30/23
- IonQ reports Q4 EPS (9c), consensus (13c)
- 11/14/22
- IonQ affirms 2022 revenue outlook $10.2M-$10.7M, consensus $10.64M
- 11/14/22
- IonQ sees Q4 revenue $2.9M-$3.4M, consensus $3.38M
- 02/02/23
- Alphabet reports Q4 EPS $1.05, consensus $1.18
- 10/25/22
- Alphabet reports Q3 EPS $1.06, consensus $1.25
- 10/25/22
- Notable companies reporting after market close
- 02/15/23
- Generac sees total Q1 sales down by 25%-26% y/y, consensus $949.14M
- 02/15/23
- Generac sees FY23 net revenue down 6%-10%, consensus $4.19B
- 02/15/23
- Generac reports Q4 adjusted EPS $1.78, consensus $1.76
- 11/02/22
- Generac sees FY22 net revenue growth 22%-24%, consensus $4.7B
- 01/31/23
- General Motors sees FY23 adjusted EPS $6.00-$7.00, consensus $5.81
- 01/31/23
- General Motors reports Q4 adjusted EPS $2.12, consensus $1.69
- 01/30/23
- Notable companies reporting before tomorrow's open
- 03/31/23
- Fathom Digital reports Q4 revenue $38.4M, consensus $40.48M
- 11/14/22
- Fathom Digital reports Q3 adj. net loss ($1.8M) vs. ($1.1M) last year
- 02/02/23
- Ford sees FY23 adjusted EBIT of $9B-$11B
- 02/02/23
- Ford reports Q4 adjusted EPS 51c, consensus 62c
- 10/26/22
- Ford reports Q3 adjusted EPS 39c, consensus 27c
- 03/29/23
- Cintas reports Q3 EPS $3.14, consensus $3.04
- 03/29/23
- Cintas raises FY23 EPS view to $12.70-$12.90 from $12.50-$12.80
- 03/29/23
- Cintas reports Q4 EPS $3.14, consensus $3.04
- 12/21/22
- Cintas raises FY23 EPS view to $12.50-$12.80 from $12.30-$12.65
- 03/01/23
- Cano Health sees FY23 revenue $3.1B-43.25B, consensus $3.26B
- 03/01/23
- Cano Health reports Q4 EPS (61c), consensus (13c)
- 11/09/22
- Cano Health lowers FY22 revenue view to $2.70B-$2.75B from $2.85B-$2.90B
- 11/09/22
- Cano Health reports Q3 EPS (23c), consensus (5c)
- 03/31/23
- Bio-Path reports 2022 EPS ($1.91) vs. ($1.55) last year
- 11/15/22
- Bio-Path reports Q3 EPS (49c) vs (29c) last year
- 03/31/23
- BIO-key reports Q4 EPS (62c) vs (26c) last year
- 03/30/23
- BlackBerry reports Q4 adjusted EPS (2c), consensus (7c)
- 03/07/23
- BlackBerry sees FY23 revenue $656M, consensus $674.73M
- 03/07/23
- BlackBerry reports preliminary Q4 revenue $151M, consensus $168.45M
- 12/20/22
- BlackBerry reports Q3 adjusted EPS (5c), consensus (7c)
- 02/21/23
- Arconic sees FY23 revenue $8B-$8.5B, consensus $8.47B
- 02/21/23
- Arconic reports Q4 EPS ($2.70) with loss, consensus 28c
- 11/01/22
- Arconic lowers FY22 revenue view to $9B-$9.3B from $9.2B-$9.5B, consensus $9.05B
- 11/01/22
- Arconic reports Q3 EPS with impairment (64c), consensus 24c
- 02/03/23
- Aon plc reports Q4 adjusted EPS $3.89, consensus $3.65
- 10/28/22
- Aon plc reports Q3 adjusted EPS $2.02, consensus $1.99
- 03/31/23
- Aehr Test Systems reiterates FY23 revenue view of at least $60M-$70M
- 03/31/23
- Aehr Test Systems reports Q3 adjusted EPS 16c, consensus 14c
- 03/02/23
- Aehr Test Systems reiterates annual guidance, comments on Tesla statements
- 01/05/23
- Aehr Test Systems reports Q2 EPS 16c, consensus 8c
- 02/02/23
- Apple reports Q1 EPS $1.88, consensus $1.94
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Apple reports Q4 EPS $1.29, consensus $1.17
- 10/27/22
- Notable companies reporting after market close
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/30/23
- Virgin Orbit unable to secure funding, to cease operations, lay off 85% of staff
- 03/22/23
- Virgin Orbit confirms incremental resumption of operations
- 03/16/23
- Virgin Orbit confirms operational pause amid discussions for funding
- 02/14/23
- Virgin Orbit provides update on U.K. mission anomaly
- 03/28/23
- Viking Therapeutics initiates Phase 1 study of novel formulation of VK2735
- 03/28/23
- Viking Therapeutics jumps 32% to $12.06 after Phase 1 VK2735 trial results
- 03/28/23
- Viking Therapeutics announces results from Phase 1 trial of VK2735
- 01/09/23
- Viking Therapeutics completes enrollment in Phase 2b VOYAGE study of VK2809
- 03/13/23
- Thorne HealthTech appoints Varma as new CFO
- 02/03/23
- Thorne HealthTech acquires PreCon Health for $5M
- 01/09/23
- Appeals Court upholds Thorne HealthTech's prior challenge of NR IP claim
- 10/25/22
- Thorne HealthTech and Gentegra collaborate for DNA collection kit
- 03/29/23
- Semtech falls 8% to $29.40 after Q4 earnings miss, below-consensus guidance
- 03/28/23
- Semtech announces first LoRa-enabled third party products available
- 03/20/23
- Semtech enters into cooperation agreement with Lion Point Capital
- 03/16/23
- Semtech CEO Mohan Maheswaran to retire
- 03/31/23
- Rogers Communications sees 2023 service revenue up 26%-30%
- 03/31/23
- Rogers Communications, Shaw Communications to proceed with merger
- 03/31/23
- Rogers, Shaw, Quebecor to close pro-competitive transactions
- 02/17/23
- Shaw Communications extends date for annual general meeting
RCI Rogers Communications - 02/17/23
- Rogers, Shaw, Quebecor extend outside date of proposed transactions
- $11.19 /
+1.435 (+14.71%) - 03/28/23
- Pacific Biosciences announces new workflows developed with Corteva
- 03/07/23
- Pacific Biosciences begins commercial shipment of Revio sequencing systems
- 01/09/23
- Pacific Biosciences partners with University of Tokyo
- 03/30/23
- Chart Industries, Nikola execute strategic partnership
- 03/29/23
- Nikola, Klean Industries partner to convert truck fleets to FCEVs
- 03/29/23
- Nikola says has received orders for 100 Class 8 FCEVs
- 03/27/23
- Nikola CFO Kim Brady to retire, Anastasiya Pasterick to succeed
- 03/09/23
- Verizon offers one year of Netflix for free through its +play subscription hub
- 02/22/23
- Netflix announces first partnership with NFL for 'Quarterback' docu-series
- 02/08/23
- Netflix provides update on sharing guidelines as 100M households share accounts
- 02/02/23
- Netflix, GM partner to increase EV presence in Netflix-produced shows, films
- 03/31/23
- CAC announces cybersecurity review of Micron products selling in China
- 03/28/23
- Micron says now expects overall headcount reduction to approach 15%
- 03/28/23
- Micron says further reducing supply
- 03/28/23
- Micron up 2% after Q2 report
- 03/30/23
- JD.com intends to spin-off JD Property, JD Industrials
- 03/09/23
- JD.com initiates quarterly dividend of 62c per ADS
- 01/31/23
- Dada Nexus, JD.com announce results from JD Shop Now Spring Festival
- 12/27/22
- China stocks rising with borders set to reopen on January 8
- 03/31/23
- IonQ rises 29.9%
- 03/31/23
- IonQ rises 21.9%
- 03/31/23
- IonQ rises 6.9%
- 03/21/23
- IonQ mentioned by Nvidia among partners integrating CUDA Quantum
- 03/29/23
- Verint announces expanded partnership with Google Cloud
- 03/29/23
- Verint announces expanded partnership with Google CloudAlphabet
- 03/28/23
- Google teams with AI firm Replit to aid generative AI for software development
- 03/28/23
- ADT Inc., Google announce availability of ADT Self Setup home security system
- 03/30/23
- Globant expands global partnership with Google Cloud
- 03/31/23
- Generac falls -5.7%
- 03/31/23
- Generac falls -5.6%
- 03/07/23
- Generac makes strategic minority investment in Rolling Energy Resources
- 01/31/23
- Generac announces home standby generator integration with ecobee smart
- 03/22/23
- GM says sixth generation Chevrolet Camaro to retire at conclusion of 2024
- 03/22/23
- General Motors selects Adobe Experience Cloud
- 03/21/23
- EU passenger car registrations up 11.5% in February
- 03/09/23
- General Motors announces voluntary separation program
- 03/30/23
- Ford withdraws self-driving petition with NHTSA
- 03/30/23
- Ford enters three-party collaboration to advance nickel production in Indonesia
- 03/26/23
- Fly Intel: Top five weekend stock stories
- 03/24/23
- Ford says 'on track' with construction at BlueOval City mega-campus
- 03/20/23
- Peltz says not out of Disney, but 'not in as much as we were'
- 03/13/23
- Disney CHRO Paul Richardson to depart, Sonia Coleman to succeed
- 02/26/23
- Fly Intel: Top five weekend stock stories
- 02/21/23
- Disney reports 'Ant-Man and The Wasp: Quantumania' opening totals $249.7M
- 12/16/22
- Cintas launches electric vehicle pilot program
- 11/15/22
- Cintas expands cleanroom footprint with new facility in New York
- 03/31/23
- Cano Health 'disappointed that three directors chose to resign'
- 03/30/23
- Cano Health's Barry Sternlicht resigns from board
- 02/14/23
- Third Point buys AIG, exits T-Mobile in Q4
- 10/17/22
- Cano Health falls -12.5%
- 03/16/23
- Bio-Path provides clinical, operational update
- 12/07/22
- Bio-Path announces first patient dosed in Phase 1/1b study of BP1001-A
- 11/07/22
- Bio-Path announces $2M registered direct offering, private placement
- 10/24/22
- Bio-Path announces first patient dosed in Phase 1/1b study of BP1002
- 03/28/23
- BIO-key strategically teams with Ethnos IT Solutions expanding Africa reach
- 03/14/23
- BIO-key, BeyondTrust announce integrated partnership
- 02/27/23
- City of Brawley, CA selects BIO-key's PortalGuard IDaaS platform
- 02/13/23
- BIO-key partners with Europe's Bravantic Group
- 03/31/23
- BlackBerry rises 14.8%
- 03/23/23
- BlackBerry, Adobe partner on secure forms solution for mobile
- 03/21/23
- BlackBerry to sell non-core patents, applications to Malikie for $900M
- 03/07/23
- BlackBerry falls -13.3%
- 11/10/22
- Aon acquires risk assessment modeling firm ERN, terms not disclosed
- 03/31/23
- Aehr Test Systems provides update on ATM offering
- 03/21/23
- Aehr Test receives order from major silicon carbide semiconductor customer
- 03/14/23
- Aehr Test Systems receives $6.7M order for FOX WaferPak full water Contactors
- 03/10/23
- Aehr Test Systems believes 'no impact' to operations due to closure of SVB
- $163.13 /
+0.755 (+0.46%) - 03/30/23
- VirnetX disagrees with Federal Circuit's decision, evaluating options
- 03/30/23
- VirnetX lower after denied appeal in patent fight with Apple
- 03/30/23
- VirnetX enters cooperation agreement with Bradley Radoff and Michael Torok
- 03/29/23
- Apple WWDC to run from June 5-9
- 03/31/23 Wedbush
- Wedbush says 'difficult to understand ramifications' of China's Micron review
- 03/29/23 Needham
- Micron price target raised to $71 from $67 at Needham
- 03/29/23 Susquehanna
- Micron price target raised to $90 from $65 at Susquehanna
- 03/29/23 TD Cowen
- Micron price target raised to $70 from $66 at TD Cowen
- 03/31/23 TD Securities
- BlackBerry upgraded to Hold at TD Securities following 68% decline
- 03/31/23 TD Securities
- BlackBerry upgraded to Hold from Reduce at TD Securities
- 03/08/23 RBC Capital
- BlackBerry price target lowered to C$4.50 from C$5.50 at RBC Capital
- 12/21/22 Canaccord
- BlackBerry price target lowered to $4.50 from $5.00 at Canaccord
- 03/31/23 BTIG
- BTIG downgrades Nikola to Neutral after stock offering, expects further dilution
- 03/31/23 BTIG
- Nikola downgraded to Neutral from Buy at BTIG
- 03/13/23 Morgan Stanley
- Nikola initiated with an Equal Weight at Morgan Stanley
- 02/24/23 Deutsche Bank
- Nikola price target lowered to $3 from $5 at Deutsche Bank
- 03/17/23 Canaccord
- Virgin Orbit rating, target put under review at Canaccord after operations halt
- 01/11/23 Canaccord
- Virgin Orbit price target lowered to $6 from $12
- 10/11/22 Credit Suisse
- Virgin Orbit initiated with Underperform on elevated cash burn at Credit Suisse
- 10/11/22 Credit Suisse
- Virgin Orbit initiated with an Underperform at Credit Suisse
- 03/29/23 Wells Fargo
- Netflix update on sharing efforts likely a positive catalyst, says Wells Fargo
- 03/20/23 JPMorgan
- Netflix Paid Sharing launches bring near-term 'noise,' says JPMorgan
- 03/16/23 Citi
- Netflix price target raised to $400 from $395 at Citi
- 03/15/23 Oppenheimer
- Netflix share pullback brings buying opportunity, says Oppenheimer
- 03/27/23 Citi
- General Motors price target lowered to $76 from $82 at Citi
- 03/21/23 Morgan Stanley
- EV price cuts 'not a fad, but a trend,' says Morgan Stanley
- 03/09/23 Citi
- WSJ report on GM didn't contain new information, says Citi
- 02/24/23 BofA
- GM should be bought, not sold, on truck production cut, says BofA
- $163.13 /
+0.755 (+0.46%) - 03/30/23 Needham
- Disney and Apple worth more together than separately, says Needham
- 03/28/23 Mizuho
- Apple 'Pay Later' should already be reflected in Affirm price, says Mizuho
- 03/28/23 Barclays
- Apple advertising on own apps is underappreciated, says Barclays
- 03/21/23 Morgan Stanley
- Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley
- 03/31/23 Piper Sandler
- Piper cuts Alphabet target on 'real risk' to Search revenue from AI
- 03/30/23 Credit Suisse
- YouTube engagement remains steady, says Credit Suisse
- 03/29/23 Morgan Stanley
- TikTok ban could put 53B U.S. consumer hours 'up for grabs,' says Morgan Stanley
- 03/29/23 KeyBanc
- Microsoft price target raised to $316 from $270 at KeyBanc
- 03/24/23 Barclays
- Meta Platforms price target raised to $270 from $260 at Barclays
- 01/06/23 UBS
- Cano Health downgraded to Neutral from Buy at UBS
- 01/05/23 Wolfe Research
- Cano Health downgraded to Peer Perform from Outperform at Wolfe Research
- 12/13/22 Citi
- Citi opens 'positive Catalyst Watch' on Cano Health
- 12/13/22 BofA
- BofA resumes Cano Health at Underperform, sees potential more guidance cuts
- $11.19 /
+1.435 (+14.71%) - 03/31/23 TD Cowen
- Pacific Biosciences upgraded to Outperform from Market Perform at TD Cowen
- 02/22/23 Piper Sandler
- Pacific Biosciences price target lowered to $10 from $11 at Piper Sandler
- 02/02/23 UBS
- Pacific Biosciences initiated with a Neutral at UBS
- 01/20/23 Cantor Fitzgerald
- Pacific Biosciences downgraded to Neutral at Cantor Fitzgerald on valuation
- 03/31/23 Jefferies
- Cintas downgraded to Hold from Buy at Jefferies
- 03/30/23 BofA
- Cintas price target raised to $523 from $513 at BofA
- 03/30/23 Argus
- Cintas price target raised to $510 from $500 at Argus
- 03/30/23 Stifel
- Cintas price target raised to $512 from $503 at Stifel
- 03/31/23 Loop Capital
- JD.com cut to Hold at Loop Capital amid continued competitive concerns
- 03/30/23 Loop Capital
- JD.com downgraded to Hold from Buy at Loop Capital
- 03/13/23 Susquehanna
- JD.com price target lowered to $45 from $62 at Susquehanna
- 03/13/23 Barclays
- JD.com price target raised to $74 from $72 at Barclays
- 03/31/23 BofA
- Generac downgraded to Underperform from Neutral at BofA
- 03/09/23 Citi
- Generac transferred with Neutral from Buy at Citi
- 03/03/23 Oppenheimer
- Generac price target raised to $145 from $137 at Oppenheimer
- 03/02/23 Scotiabank
- Generac initiated with a Sector Perform at Scotiabank
- 03/31/23 JPMorgan
- Aon plc price target raised to $322 from $320 at JPMorgan
- 02/14/23 Stifel
- Willis Towers Watson price target raised to $255 from $228 at Stifel
- 02/06/23 Piper Sandler
- Aon plc price target raised to $325 from $305 at Piper Sandler
- 01/19/23 BMO Capital
- Aon plc initiated with a Market Perform at BMO Capital
- 03/15/23 Wells Fargo
- Wells says Disney investors wanting Hulu sale could be disappointed
- 03/02/23 Citi
- Disney may sell its 67% stake in Hulu, says Citi
- 02/13/23 JPMorgan
- Disney reinstated with an Overweight at JPMorgan
- 03/27/23 Citi
- Ford price target lowered to $12.50 from $14 at Citi
- 02/15/23 Tudor Pickering
- Ford downgraded to Hold from Buy at Tudor Pickering
- 02/14/23 Barclays
- Barclays starts autos and mobility sector, says Tesla stands out
- 01/13/23 Scotiabank
- Shaw Communications downgraded to Sector Perform from Outperform at Scotiabank
- 01/13/23 Scotiabank
- Shaw Communications downgraded to Sector Perform from Outperform at Scotiabank
- 01/13/23 Desjardins
- Shaw Communications downgraded to Hold from Buy at Desjardins
- 01/10/23 Canaccord
- Shaw Communications downgraded to Hold from Buy at Canaccord
- 03/31/23 Baird
- Semtech price target lowered to $40 from $48 at Baird
- 03/30/23 Stifel
- Semtech price target lowered to $37 from $40 at Stifel
- 03/30/23 TD Cowen
- Semtech price target lowered to $28 from $33 at TD Cowen
- 03/30/23 Susquehanna
- Semtech price target lowered to $30 from $32 at Susquehanna
- 03/29/23 Truist
- Viking Therapeutics price target raised to $32 from $28 at Truist
- 03/29/23 Roth MKM
- Viking Therapeutics price target raised to $19 from $15 at Roth MKM
- 03/29/23 Maxim
- Viking Therapeutics price target raised to $25 from $15 at Maxim
- 03/29/23 Raymond James
- Viking Therapeutics price target raised to $35 from $12 at Raymond James
- 01/20/23 Craig-Hallum
- Aehr Test Systems price target raised to $45 from $31 at Craig-Hallum
- 10/17/22 William Blair
- Aehr Test Systems initiated with an Outperform at William Blair
- 11/16/22 Benchmark
- IonQ price target lowered to $8 from $12 at Benchmark
- 08/16/22 Benchmark
- IonQ price target lowered to $12 from $15 at Benchmark
- 07/15/22 Goldman Sachs
- IonQ price target lowered to $8 from $10 at Goldman Sachs
- 06/08/22 Needham
- Needham starts IonQ at Buy as market leader in ion trap quantum computers
- 05/18/22 H.C. Wainwright
- Bio-Path price target lowered to $9 from $12 at H.C. Wainwright
- 11/11/22 JPMorgan
- Fathom Digital initiated with an Overweight at JPMorgan
- 08/16/22 Needham
- Fathom Digital price target lowered to $6 from $9 at Needham
- 05/17/22 Needham
- Fathom Digital price target lowered to $9 from $12 at Needham
- 05/13/22 BofA
- Fathom Digital initiated with a Neutral at BofA
- 11/16/22 Canaccord
- Thorne HealthTech initiated with Buy, $5.50 target at Canaccord
- 11/16/22 Canaccord
- Thorne HealthTech initiated with a Buy at Canaccord
- 08/11/22 TD Cowen
- Thorne HealthTech price target lowered to $8 from $12 at Cowen
RCI Rogers Communications - 02/06/23 UBS
- Rogers Communications upgraded to Buy from Neutral at UBS
- 02/03/23 Canaccord
- Rogers Communications price target raised to C$69 from C$68 at Canaccord
- 02/03/23 TD Securities
- Rogers Communications price target raised to C$78 from C$76 at TD Securities
- 02/03/23 Canaccord
- Rogers Communications price target raised to C$69 from C$68 at Canaccord
- 02/08/23
- Viking Therapeutics reports Q4 EPS (26c), consensus (23c)
- 10/26/22
- Viking Therapeutics reports Q3 EPS (21c), consensus (23c)
- 03/30/23
- Thorne HealthTech sees FY23 adjusted EPS 37c-39c, consensus 64c
- 03/30/23
- Thorne HealthTech reports Q4 adjusted EPS 13c vs. 7c last year
- 03/29/23
- Semtech sees Q1 EPS (11c)-(4c), consensus 43c
- 03/29/23
- Semtech reports Q4 EPS 47c, consensus 48c
- 11/30/22
- Semtech sees Q4 adjusted EPS 44c-52c, consensus 54c
- 11/30/22
- Semtech reports Q3 adjusted EPS 65c, consensus 63c
- 01/12/23
- Shaw Communications reports Q1 EPS C$0.34 vs. C$0.39 last year
- 11/29/22
- Shaw Communications reports Q4 EPS C$0.34, versus C$0.50 last year
RCI Rogers Communications - 02/02/23
- Rogers Communications sees 2023 service revenue up 4%-7%
- 02/02/23
- Rogers Communications reports Q4 adjusted EPS C$1.09 vs. C$0.96 last year
- 11/09/22
- Rogers Communications reports Q3 adjusted EPS C$0.84 vs C$1.03 last year
- $11.19 /
+1.435 (+14.71%) - 02/16/23
- Pacific Biosciences reports Q4 adjusted EPS (35c), consensus (36c)
- 01/09/23
- Pacific Biosciences sees Q4 revenue $27.3M, consensus $27.88M
- 11/07/22
- Pacific Biosciences withdraws all prior financial guidance
- 11/07/22
- Pacific Biosciences reports Q3 EPS (32c), consensus (33c)
- 02/23/23
- Nikola reports Q4 adjusted EPS (37c), consensus (43c)
- 02/22/23
- Notable companies reporting before tomorrow's open
- 11/03/22
- Nikola reports Q3 adjusted EPS (28c), consensus (39c)
- 01/19/23
- Netflix sees Q1 EPS $2.82, consensus $2.97
- 01/19/23
- Netflix reports Q4 EPS 12c, consensus 45c
- 01/19/23
- Notable companies reporting after market close
- 10/18/22
- Netflix sees Q4 EPS 36c, consensus $1.12
- 03/28/23
- Micron sees Q3 adjusted EPS ($1.65)-($1.51), consensus (90c)
- 03/28/23
- Micron reports Q2 adjusted EPS ($1.91), consensus (86c)
- 03/28/23
- Notable companies reporting after market close
- 03/02/23
- Micron sees lower margins in fiscal Q3 than previously expected
- 03/09/23
- JD.com reports Q4 EPS 70c, consensus 50c
- 03/08/23
- Notable companies reporting before tomorrow's open
- 11/18/22
- JD.com reports Q3 EPS 88c, consensus 63c
- 03/30/23
- IonQ sees FY23 revenue $18.4M-$18.8M, consensus $18.2M
- 03/30/23
- IonQ reports Q4 EPS (9c), consensus (13c)
- 11/14/22
- IonQ affirms 2022 revenue outlook $10.2M-$10.7M, consensus $10.64M
- 11/14/22
- IonQ sees Q4 revenue $2.9M-$3.4M, consensus $3.38M
- 02/02/23
- Alphabet reports Q4 EPS $1.05, consensus $1.18
- 10/25/22
- Alphabet reports Q3 EPS $1.06, consensus $1.25
- 10/25/22
- Notable companies reporting after market close
- 02/15/23
- Generac sees total Q1 sales down by 25%-26% y/y, consensus $949.14M
- 02/15/23
- Generac sees FY23 net revenue down 6%-10%, consensus $4.19B
- 02/15/23
- Generac reports Q4 adjusted EPS $1.78, consensus $1.76
- 11/02/22
- Generac sees FY22 net revenue growth 22%-24%, consensus $4.7B
- 01/31/23
- General Motors sees FY23 adjusted EPS $6.00-$7.00, consensus $5.81
- 01/31/23
- General Motors reports Q4 adjusted EPS $2.12, consensus $1.69
- 01/30/23
- Notable companies reporting before tomorrow's open
- 03/31/23
- Fathom Digital reports Q4 revenue $38.4M, consensus $40.48M
- 11/14/22
- Fathom Digital reports Q3 adj. net loss ($1.8M) vs. ($1.1M) last year
- 02/02/23
- Ford sees FY23 adjusted EBIT of $9B-$11B
- 02/02/23
- Ford reports Q4 adjusted EPS 51c, consensus 62c
- 10/26/22
- Ford reports Q3 adjusted EPS 39c, consensus 27c
- 02/08/23
- Disney reports Q1 EPS ex-items 99c, consensus 78c
- 02/08/23
- Notable companies reporting after market close
- 11/08/22
- Disney CFO sees FY23 cash content spend in low-$30B range
- 11/08/22
- Disney reports Q4 EPS ex-items 30c, consensus 57c
- 03/29/23
- Cintas reports Q3 EPS $3.14, consensus $3.04
- 03/29/23
- Cintas raises FY23 EPS view to $12.70-$12.90 from $12.50-$12.80
- 03/29/23
- Cintas reports Q4 EPS $3.14, consensus $3.04
- 12/21/22
- Cintas raises FY23 EPS view to $12.50-$12.80 from $12.30-$12.65
- 03/01/23
- Cano Health sees FY23 revenue $3.1B-43.25B, consensus $3.26B
- 03/01/23
- Cano Health reports Q4 EPS (61c), consensus (13c)
- 11/09/22
- Cano Health lowers FY22 revenue view to $2.70B-$2.75B from $2.85B-$2.90B
- 11/09/22
- Cano Health reports Q3 EPS (23c), consensus (5c)
- 03/31/23
- Bio-Path reports 2022 EPS ($1.91) vs. ($1.55) last year
- 11/15/22
- Bio-Path reports Q3 EPS (49c) vs (29c) last year
- 03/31/23
- BIO-key reports Q4 EPS (62c) vs (26c) last year
- 03/30/23
- BlackBerry reports Q4 adjusted EPS (2c), consensus (7c)
- 03/07/23
- BlackBerry sees FY23 revenue $656M, consensus $674.73M
- 03/07/23
- BlackBerry reports preliminary Q4 revenue $151M, consensus $168.45M
- 12/20/22
- BlackBerry reports Q3 adjusted EPS (5c), consensus (7c)
- 02/03/23
- Aon plc reports Q4 adjusted EPS $3.89, consensus $3.65
- 10/28/22
- Aon plc reports Q3 adjusted EPS $2.02, consensus $1.99
- 03/31/23
- Aehr Test Systems reiterates FY23 revenue view of at least $60M-$70M
- 03/31/23
- Aehr Test Systems reports Q3 adjusted EPS 16c, consensus 14c
- 03/02/23
- Aehr Test Systems reiterates annual guidance, comments on Tesla statements
- 01/05/23
- Aehr Test Systems reports Q2 EPS 16c, consensus 8c
- $163.13 /
+0.755 (+0.46%) - 02/02/23
- Apple reports Q1 EPS $1.88, consensus $1.94
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Apple reports Q4 EPS $1.29, consensus $1.17
- 10/27/22
- Notable companies reporting after market close
|
|
On The Fly
|
The most talked about and… ShowHide Related Items >><< - 01/05/23
- Zimmer Biomet to acquire Embody for $155M at closing
- 11/30/22
- NeuroOne Medical ships initial Zimmer Biomet order for Evo sEEG system
- 11/21/22
- Zimmer Biomet announces FDA 510(k) clearance of Persona OsseoTi Keel Tibia
- 11/05/22
- Zimmer Biomet announces one-year data from mymobility clinical study
- 02/13/23
- U.S. video game spending fell 5% y/y in January, says NPD
- 01/19/23
- Sony announces additional games coming to PlayStation VR2
- 01/17/23
- U.S. video game consumer spending rose 2% y/y in December, says NPD
- 03/30/23
- Avidity Biosciences provides regulatory update on dystrophy candidate AOC 1001
- 02/27/23
- Avidity Biosciences advances RNA programs, expands into new therapeutic areas
- 02/14/23
- Avidity Biosciences' AOC 1020 granted Orphan Drug designation in FSHD
- 02/13/23
- Avidity Biosciences treatment of FSHD granted orphan designation
- 02/10/23
- Healthpeak announces closing of holding company reorganization
- 10/06/22
- Healthpeak CEO Tom Herzog steps down, Scott Brinker succeeds
- 03/28/23
- Pacific Biosciences announces new workflows developed with Corteva
- 03/07/23
- Pacific Biosciences begins commercial shipment of Revio sequencing systems
- 01/09/23
- Pacific Biosciences partners with University of Tokyo
- 02/14/23
- Berkshire added more of top-holding Apple, Paramount in Q4
- 03/30/23
- JD.com intends to spin-off JD Property, JD Industrials
- 03/09/23
- JD.com initiates quarterly dividend of 62c per ADS
- 01/31/23
- Dada Nexus, JD.com announce results from JD Shop Now Spring Festival
- 12/27/22
- China stocks rising with borders set to reopen on January 8
- 03/16/23
- Del Taco, Samuel Adams Boston Lager enter collaboration
- 03/01/23
- Jack in the Box signs 14 new restaurant commitments
- 01/09/23
- Jack in the Box says Q1 SSS accelerated to mid- to high-single digits
- 01/05/23
- Jack in the Box 's Del Taco opens new location in New Mexico
- 02/22/23
- Immunocore announces initial Phase 1 data for IMC-M113V
- 01/09/23
- Immunocore reports Q4 KIMMTRAK, tebentafusp sales of $50M
- 01/09/23
- Immunocore announces strategic priorities for 2023
- 12/08/22
- Immunocore presents ovarian cancer expansion data for IMC-C103C
- 01/25/23
- Integral Ad Science, Twitter launch Tweet-level brand safety insights
- 01/23/23
- Integral Ad Science appoints Kevin Alvero as head of global compliance
- 11/29/22
- Integral Ad Science appoints Khurrum Malik as chief marketing officer
- 11/10/22
- Integral Ad Science names CFO, effective December 5
- 02/21/23
- Howmet Aerospace CFO sells $4.79M in common stock
- 02/14/23
- Elliott buys NiSource, cuts Aerojet in Q4
- 11/14/22
- Elliott made Triple Flag Precious Metals top holding during Q3
- 10/11/22
- Howmet Aerospace has taken $65M pre tax charge in Q3
- 03/31/23
- Generac falls -5.6%
- 03/07/23
- Generac makes strategic minority investment in Rolling Energy Resources
- 01/31/23
- Generac announces home standby generator integration with ecobee smart
- 01/31/23
- Generac introduces electric vehicle charging system
- 03/30/23
- Dice Therapeutics discloses $14.8M purchase of common stock by Ra Capital
- 10/11/22
- Dice Therapeutics jumps 83% to $45.02 after Phase 1 trial data of DC-806
- 10/11/22
- Dice Therapeutics reports results from Phase 1 clinical trial of DC-806
- 12/16/22
- Cintas launches electric vehicle pilot program
- 11/15/22
- Cintas expands cleanroom footprint with new facility in New York
- 03/23/23
- BlackBerry, Adobe partner on secure forms solution for mobile
- 03/21/23
- BlackBerry to sell non-core patents, applications to Malikie for $900M
- 03/07/23
- BlackBerry falls -13.3%
- 03/07/23
- BlackBerry falls -10.7%
- 01/24/23
- AmerisourceBergen to change name to Cencora
- 01/24/23
- AmerisourceBergen plans to change name to Cencora
- 12/30/22
- AmerisourceBergen calls DOJ complaint 'an attempt to shift blame' from DEA
- 12/29/22
- Justice Department files civil complaint against AmerisourceBergen over opioids
- 03/31/23 Jefferies
- Cintas downgraded to Hold from Buy at Jefferies
- 03/30/23 BofA
- Cintas price target raised to $523 from $513 at BofA
- 03/30/23 Argus
- Cintas price target raised to $510 from $500 at Argus
- 03/30/23 Stifel
- Cintas price target raised to $512 from $503 at Stifel
- 03/31/23 Benchmark
- Benchmark upgrades Howmet Aerospace to Buy on recent large orders
- 03/31/23 Benchmark
- Howmet Aerospace upgraded to Buy from Hold at Benchmark
- 03/22/23 Jefferies
- Howmet Aerospace initiated with a Buy at Jefferies
- 02/21/23 Argus
- Howmet Aerospace price target raised to $49 from $43 at Argus
- 03/31/23 BofA
- Generac downgraded to Underperform from Neutral at BofA
- 03/09/23 Citi
- Generac transferred with Neutral from Buy at Citi
- 03/03/23 Oppenheimer
- Generac price target raised to $145 from $137 at Oppenheimer
- 03/02/23 Scotiabank
- Generac initiated with a Sector Perform at Scotiabank
- 03/31/23 TD Cowen
- Pacific Biosciences upgraded to Outperform from Market Perform at TD Cowen
- 02/22/23 Piper Sandler
- Pacific Biosciences price target lowered to $10 from $11 at Piper Sandler
- 02/02/23 UBS
- Pacific Biosciences initiated with a Neutral at UBS
- 01/20/23 Cantor Fitzgerald
- Pacific Biosciences downgraded to Neutral at Cantor Fitzgerald on valuation
- 03/31/23 Citi
- McKesson initiated with a Buy at Citi
- 02/02/23 Morgan Stanley
- McKesson price target raised to $426 from $420 at Morgan Stanley
- 02/02/23 Baird
- McKesson price target raised to $450 from $445 at Baird
- 01/31/23 UBS
- McKesson price target lowered to $440 from $450 at UBS
- 03/31/23 Citi
- AmerisourceBergen initiated with a Buy at Citi
- 02/02/23 Baird
- AmerisourceBergen price target raised to $201 from $199 at Baird
- 02/02/23 Mizuho
- AmerisourceBergen price target raised to $170 from $162 at Mizuho
- 01/31/23 UBS
- AmerisourceBergen price target raised to $190 from $184 at UBS
- 03/31/23 Jefferies
- Zimmer Biomet upgraded to Hold from Underperform at Jefferies
- 03/29/23 UBS
- Zimmer Biomet initiated with a Sell at UBS
- 03/28/23 UBS
- Zimmer Biomet initiated with a Sell at UBS
- 03/10/23 Piper Sandler
- Zimmer upgraded to Overweight on 'conservative' outlook at Piper Sandler
- 03/31/23 TD Securities
- BlackBerry upgraded to Hold at TD Securities following 68% decline
- 03/31/23 TD Securities
- BlackBerry upgraded to Hold from Reduce at TD Securities
- 03/08/23 RBC Capital
- BlackBerry price target lowered to C$4.50 from C$5.50 at RBC Capital
- 12/21/22 Canaccord
- BlackBerry price target lowered to $4.50 from $5.00 at Canaccord
- 03/30/23 Mizuho
- Immunocore initiated with a Buy at Mizuho
- 03/30/23 Guggenheim
- Guggenheim starts TCR immunotherapies 'pioneer' Immunocore with a Buy
- 03/30/23 Guggenheim
- Immunocore initiated with a Buy at Guggenheim
- 03/24/23 Bryan Garnier
- Immunocore initiated with a Buy at Bryan Garnier
- 03/31/23 Loop Capital
- Loop Capital starts Jack in the Box at Buy, sees comps 'recovering nicely'
- 03/30/23 Loop Capital
- Jack in the Box initiated with a Buy at Loop Capital
- 03/02/23 Truist
- Jack in the Box price target raised to $98 from $92 at Truist
- 03/02/23 Deutsche Bank
- Jack in the Box price target raised to $81 from $75 at Deutsche Bank
- 03/31/23 Loop Capital
- JD.com cut to Hold at Loop Capital amid continued competitive concerns
- 03/30/23 Loop Capital
- JD.com downgraded to Hold from Buy at Loop Capital
- 03/13/23 Susquehanna
- JD.com price target lowered to $45 from $62 at Susquehanna
- 03/13/23 Barclays
- JD.com price target raised to $74 from $72 at Barclays
- 03/27/23 Barclays
- Tencent price target raised to $50 from $48 at Barclays
- 01/25/23 Barclays
- Tencent price target raised to $48 from $36 at Barclays
- 01/05/23 Mizuho
- Tencent price target raised to HK$330 from HK$300 at Mizuho
- 03/31/23 Evercore ISI
- Avidity Biosciences downgraded to In Line at Evercore on safety concerns
- 03/31/23 Evercore ISI
- Avidity Biosciences downgraded to In Line from Outperform at Evercore ISI
- 02/27/23 Raymond James
- Dyne Therapeutics upgraded to Strong Buy from Outperform at Raymond James
- 12/14/22 Credit Suisse
- Avidity Biosciences price target raised to $35 from $33 at Credit Suisse
- 03/31/23 Scotiabank
- Healthpeak downgraded at Scotiabank on Life Science segment's tougher outlook
- 03/31/23 Scotiabank
- Healthpeak downgraded to Sector Perform from Outperform at Scotiabank
- 01/03/23 Jefferies
- Healthpeak upgraded to Buy at Jefferies with stability prioritized
- 01/02/23 Jefferies
- Healthpeak upgraded to Buy from Hold at Jefferies
- 03/31/23 Needham
- Dice Therapeutics initiated with a Buy at Needham
- 03/01/23 TD Cowen
- Dice Therapeutics initiated with an Outperform at Cowen
- 11/15/22 Guggenheim
- Dice Therapeutics initiated with a Buy at Guggenheim
- 10/11/22 BofA
- Dice Therapeutics price target raised to $62 from $34 at BofA
- 03/31/23 Craig-Hallum
- Integral Ad Science initiated with a Buy at Craig-Hallum
- 03/31/23 Craig-Hallum
- Integral Ad Science initiated with a Buy at Craig-Hallum
- 03/03/23 Barclays
- Integral Ad Science price target raised to $11 from $10 at Barclays
- 01/26/23 Evercore ISI
- Integral Ad Science added to 'Tactical Underperform' list at Evercore ISI
- 02/03/23
- Zimmer Biomet sees FY23 adjusted EPS $6.95-$7.15, consensus $6.98
- 02/03/23
- Zimmer Biomet reports Q4 EPS $1.88, consensus $1.83
- 02/02/23
- Notable companies reporting before tomorrow's open
- 02/28/23
- Avidity Biosciences reports Q4 EPS (88c), consensus (89c)
- 11/08/22
- Avidity Biosciences reports Q3 EPS (82c), consensus (93c)
- 02/07/23
- Healthpeak sees FY23 adjusted FFO $1.70-$1.76, consensus $1.79
- 02/07/23
- Healthpeak reports Q4 adjusted FFO 44c, consensus 43c
- 11/01/22
- Healthpeak raises FY22 Nareit FFO view to $1.70-$1.76 to $1.67-$1.69
- 11/01/22
- Healthpeak reports Q3 NAREIT FFO 42c, consensus 43c
- 02/16/23
- Pacific Biosciences reports Q4 adjusted EPS (35c), consensus (36c)
- 01/09/23
- Pacific Biosciences sees Q4 revenue $27.3M, consensus $27.88M
- 11/07/22
- Pacific Biosciences withdraws all prior financial guidance
- 11/07/22
- Pacific Biosciences reports Q3 EPS (32c), consensus (33c)
- 02/01/23
- McKesson raises FY23 EPS view to $25.75-$26.15 from $24.45-$24.95
- 02/01/23
- McKesson reports Q3 adjusted EPS $6.90, consensus $6.35
- 02/01/23
- Notable companies reporting after market close
- 11/01/22
- McKesson boosts FY23 adjusted EPS view to $24.45-$24.95 from $23.95-$24.65
- 03/09/23
- JD.com reports Q4 EPS 70c, consensus 50c
- 03/08/23
- Notable companies reporting before tomorrow's open
- 11/18/22
- JD.com reports Q3 EPS 88c, consensus 63c
- 03/01/23
- Jack in the Box reports Q1 operating EPS $2.01, consensus $1.75
- 11/22/22
- Jack in the Box sees FY23 operating EPS $5.25-$5.65, consensus $6.59
- 11/22/22
- Jack in the Box reports Q4 operating EPS $1.33, consensus $1.36
- 03/01/23
- Immunocore reports Q4 EPS (63c), consensus 0c
- 11/09/22
- Immunocore reports Q3 EPS GBP0.13 vs. (GBP0.69) last year
- 03/02/23
- Integral Ad Science sees FY23 revenue $453M-$463M, consensus $458.75M
- 03/02/23
- Integral Ad Science sees Q1 revenue $102M-$104M, consensus $96.3M
- 03/02/23
- Integral Ad Science reports Q4 EPS 7c, consensus 1c
- 11/10/22
- Integral Ad Science sees FY22 revenue $401M-$403M, consensus $400.37M
- 02/14/23
- Howmet Aerospace sees FY23 EPS $1.53 -$1.67 , consensus $1.73
- 02/14/23
- Howmet Aerospace sees1 Q EPS 35c-39c, consensus 38c
- 02/14/23
- Howmet Aerospace reports Q4 EPS 38c, consensus 38c
- 02/13/23
- Notable companies reporting before tomorrow's open
- 02/15/23
- Generac sees total Q1 sales down by 25%-26% y/y, consensus $949.14M
- 02/15/23
- Generac sees FY23 net revenue down 6%-10%, consensus $4.19B
- 02/15/23
- Generac reports Q4 adjusted EPS $1.78, consensus $1.76
- 11/02/22
- Generac sees FY22 net revenue growth 22%-24%, consensus $4.7B
- 03/15/23
- Dice Therapeutics reports Q4 EPS (51c), consensus (49c)
- 11/09/22
- Dice Therapeutics reports Q EPS(55c) , consensus (60c)
- 03/29/23
- Cintas reports Q3 EPS $3.14, consensus $3.04
- 03/29/23
- Cintas raises FY23 EPS view to $12.70-$12.90 from $12.50-$12.80
- 03/29/23
- Cintas reports Q4 EPS $3.14, consensus $3.04
- 12/21/22
- Cintas raises FY23 EPS view to $12.50-$12.80 from $12.30-$12.65
- 03/30/23
- BlackBerry reports Q4 adjusted EPS (2c), consensus (7c)
- 03/07/23
- BlackBerry sees FY23 revenue $656M, consensus $674.73M
- 03/07/23
- BlackBerry reports preliminary Q4 revenue $151M, consensus $168.45M
- 12/20/22
- BlackBerry reports Q3 adjusted EPS (5c), consensus (7c)
- 02/01/23
- AmerisourceBergen raises FY23 adjusted EPS view to $11.50-$11.75
- 02/01/23
- AmerisourceBergen reports Q1 adjusted EPS $2.71, consensus $2.63
- 01/31/23
- Notable companies reporting before tomorrow's open
|
|
Downgrade
|
Jefferies analyst… Jefferies analyst Stephanie Moore downgraded Cintas to Hold from Buy with a price target of $487, down from $512. The analyst says a weaker macro environment in the second half of 2023 is not reflected in consensus estimates along with the company's tougher comps in fiscal 2024. Cintas' valuation "appears frothy at these levels," the analyst tells investors in a research note. The firm believes fiscal 2023 will be a challenging year for the business in the face of a tougher macro backdrop and says Street estimates are too high. ShowHide Related Items >><< - 12/16/22
- Cintas launches electric vehicle pilot program
- 11/15/22
- Cintas expands cleanroom footprint with new facility in New York
- 03/30/23 BofA
- Cintas price target raised to $523 from $513 at BofA
- 03/30/23 Argus
- Cintas price target raised to $510 from $500 at Argus
- 03/30/23 Stifel
- Cintas price target raised to $512 from $503 at Stifel
- 03/30/23 Baird
- Cintas price target raised to $512 from $500 at Baird
- 03/29/23
- Cintas reports Q3 EPS $3.14, consensus $3.04
- 03/29/23
- Cintas raises FY23 EPS view to $12.70-$12.90 from $12.50-$12.80
- 03/29/23
- Cintas reports Q4 EPS $3.14, consensus $3.04
- 12/21/22
- Cintas raises FY23 EPS view to $12.50-$12.80 from $12.30-$12.65
- 12/21/22
- What You Missed On Wall Street On Wednesday
- 12/21/22
- What You Missed On Wall Street This Morning
- 03/29/23
- Early notable gainers among liquid option names on March 29th
|
